Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve

NCT02722551 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT02722551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02722551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Lead sponsor
Edwards Lifesciences
Phase
Phase 1/2
Overall status
Withdrawn
Start date
November 30, 2016
Completion date
October 31, 2024
Enrollment
0 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation